Your browser doesn't support javascript.
loading
Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention: Insights From the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) Trial.
O'Donoghue, Michelle L; Bhatt, Deepak L; Stone, Gregg W; Steg, Ph Gabriel; Gibson, C Michael; Hamm, Christian W; Price, Matthew J; Prats, Jayne; Liu, Tiepu; Deliargyris, Efthymios N; Mahaffey, Kenneth W; White, Harvey D; Harrington, Robert A.
Afiliação
  • O'Donoghue ML; From Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (M.L.O., D.L.B.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY (G.W.S.); FACT, DHU FIRE, Université Paris-Diderot, Sorbonne Paris-Cité, France (G.S.); LVTS INSERM U-1148, Hôpital Bic
  • Bhatt DL; From Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (M.L.O., D.L.B.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY (G.W.S.); FACT, DHU FIRE, Université Paris-Diderot, Sorbonne Paris-Cité, France (G.S.); LVTS INSERM U-1148, Hôpital Bic
  • Stone GW; From Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (M.L.O., D.L.B.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY (G.W.S.); FACT, DHU FIRE, Université Paris-Diderot, Sorbonne Paris-Cité, France (G.S.); LVTS INSERM U-1148, Hôpital Bic
  • Steg PG; From Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (M.L.O., D.L.B.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY (G.W.S.); FACT, DHU FIRE, Université Paris-Diderot, Sorbonne Paris-Cité, France (G.S.); LVTS INSERM U-1148, Hôpital Bic
  • Gibson CM; From Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (M.L.O., D.L.B.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY (G.W.S.); FACT, DHU FIRE, Université Paris-Diderot, Sorbonne Paris-Cité, France (G.S.); LVTS INSERM U-1148, Hôpital Bic
  • Hamm CW; From Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (M.L.O., D.L.B.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY (G.W.S.); FACT, DHU FIRE, Université Paris-Diderot, Sorbonne Paris-Cité, France (G.S.); LVTS INSERM U-1148, Hôpital Bic
  • Price MJ; From Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (M.L.O., D.L.B.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY (G.W.S.); FACT, DHU FIRE, Université Paris-Diderot, Sorbonne Paris-Cité, France (G.S.); LVTS INSERM U-1148, Hôpital Bic
  • Prats J; From Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (M.L.O., D.L.B.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY (G.W.S.); FACT, DHU FIRE, Université Paris-Diderot, Sorbonne Paris-Cité, France (G.S.); LVTS INSERM U-1148, Hôpital Bic
  • Liu T; From Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (M.L.O., D.L.B.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY (G.W.S.); FACT, DHU FIRE, Université Paris-Diderot, Sorbonne Paris-Cité, France (G.S.); LVTS INSERM U-1148, Hôpital Bic
  • Deliargyris EN; From Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (M.L.O., D.L.B.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY (G.W.S.); FACT, DHU FIRE, Université Paris-Diderot, Sorbonne Paris-Cité, France (G.S.); LVTS INSERM U-1148, Hôpital Bic
  • Mahaffey KW; From Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (M.L.O., D.L.B.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY (G.W.S.); FACT, DHU FIRE, Université Paris-Diderot, Sorbonne Paris-Cité, France (G.S.); LVTS INSERM U-1148, Hôpital Bic
  • White HD; From Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (M.L.O., D.L.B.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY (G.W.S.); FACT, DHU FIRE, Université Paris-Diderot, Sorbonne Paris-Cité, France (G.S.); LVTS INSERM U-1148, Hôpital Bic
  • Harrington RA; From Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (M.L.O., D.L.B.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY (G.W.S.); FACT, DHU FIRE, Université Paris-Diderot, Sorbonne Paris-Cité, France (G.S.); LVTS INSERM U-1148, Hôpital Bic
Circulation ; 133(3): 248-55, 2016 Jan 19.
Article em En | MEDLINE | ID: mdl-26762525
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Monofosfato de Adenosina / Caracteres Sexuais / Gerenciamento Clínico / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Circulation Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Monofosfato de Adenosina / Caracteres Sexuais / Gerenciamento Clínico / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Circulation Ano de publicação: 2016 Tipo de documento: Article